Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Follow-up of Study Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product in an Imugene Ltd. Clinical Study

NCT05822427 is registered in ClinicalTrials.gov with Imugene Limited as lead sponsor.

NCT NCT05822427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05822427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Follow-up of Study Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product in an Imugene Ltd. Clinical Study
Lead sponsor
Imugene Limited
Phase
Observational
Overall status
Recruiting
Start date
August 25, 2020
Completion date
December 31, 2039
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

participants who received an allogeneic chimeric antigen receptor t-cell product (pbcar) in a precision biosciences, inc., clinical study